s just the first step, it is our hope that Panama’s rapid emergence as a leader in applied stem cell research will lead to safe, effective treatments for debilitating diseases such as rheumatoid arthritis and serve to benefit all Panamanians who suffer from it in the not-too-distant future,” said Ruben Berocal, M.D., National Secretary of Science, Technology and Innovation (SENACYT). “Oversight by the National Committee for Investigational Bioethics ensures patient safety by demanding ethical transparency and compliance with the highest levels of international standards,” he added.
For detailed information about this clinical trial visit http://www.clinicaltrials.gov. If you are a rheumatoid arthritis patient who has not responded to disease modifying anti-rheumatic drugs (DMARD) for at least 6 months you may qualify for this trial. Please email trials(at)translationalbiosciences(dot)com for more information about how to apply.
About Translational Biosciences
A subsidiary of Medistem Panama Inc., Translational Biosciences was founded solely to conduct clinical trials using adult stem cells and adult stem cell-derived products.
Translational Biosciences Web Site: http://www.translationalbiosciences.com
About Medistem Panama Inc.
Since opening its doors in 2007, Medistem Panama Inc. has developed adult stem cell-based products from human umbilical cord tissue and blood, adipose (fat) tissue and bone marrow. Medistem operates an 8000 sq. ft. ISO 9
Page: 1 2 3 Related biology technology :1
Copyright©2012 Vocus, Inc.
All rights reserved
. Ceres Announces Fiscal First Quarter 2014 Financial Results2
. Louisiana’s First Clinical Data Research Network to Be Developed Through PCORI Funding3
. First Implantation of New Intrathecal Drug Pump to Treat Chronic Pain4
. Grace Century Attends Provia Labs First Quarter Expansion Meeting January 5-105
. Texas Childrens Hospital named first Accredited Pediatric Heart Failure Institute in Texas6
. York U molecular communication researchers send worlds first text message using vodka7
. Remedy Informatics to Partner with Nemours Center for Cancer and Blood Disorders on Development of First-Ever Pediatric Oncology Registry8
. ThoroughGen Creates First Genetic Breeding Model for Thoroughbreds9
. Cells from the eye are inkjet printed for the first time10
. ASEA, LLC. to Expand Product Shipments to Mexico in First Quarter 201411
. Sangamo BioSciences Announces First Presentation Of Data From ZFP Therapeutic Program For Treatment Of Sickle Cell Disease And Beta-Thalassemia At American Society Of Hematology Meeting